Promising
Piracetam (Nootropil)
The prediction game
Call it: rising or fading?
Where does Piracetam (Nootropil) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.5/10
Piracetam is the granddaddy of nootropics and the most studied racetam, but its proven wins sit in clinical lanes like cortical myoclonus, post-stroke aphasia support, and narrow pediatric uses, not in healthy people chasing sharper focus. It earns a moderate score because the mechanism and clinical signals are real, while the healthy-user enhancement data is thin and the legal status is messy. It works best when you match it to a specific goal, source it carefully, and track one concrete outcome instead of expecting a general boost. ✅ Best for: People with a defined clinical reason such as cortical myoclonus or aphasia rehabilitation working alongside a clinician, and curious nootropic users who want a gentle, well-documented racetam as a starting point and will track a specific result before committing. ❌ Avoid if: You are pregnant, have meaningful kidney impairment, take blood thinners without medical sign-off, or face sport drug testing. Skip it too if you cannot find a tested, reputable source, if it is prescription-only where you live, or if you are hoping it replaces sleep, training, and nutrition rather than complementing them.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
In the news this week: Jonathan Roseland w/Limitless Mindset.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 0.1%
- BioHarmony Score
- 6.5/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.